Loading data for FMS — first visit, this takes a few seconds.

Alerte

Fresenius Medical Care AG (FMS)

NYSE: FMS · Prix en temps réel · USD

23.50

-0.27 (-1.14%)

À la clôture : Aug 19, 2026, 3:36 PM

-1.14% (1D)

Aucune donnée disponible

Cours acheteur	23.7
Capitalisation boursière	12.69B
Chiffre d’affaires (ttm)	19.43B
Résultat net (ttm)	937.78M
Bêta	0.84
EPS (ttm)	1.92
Ratio P/E (ttm)	12.42
P/E prévisionnel	6.57
P/B (ttm)	0.87
P/S (ttm)	0.65
Earnings Date	Nov 3, 2026

Cours vendeur	n/a
Volume	492,004
Volume moy. (20D)	734,881
Ouverture	23.77
Clôture précédente	23.77
Fourchette du jour	23.50 - 23.86
Intervalle de 52 semaines	20.02 - 27.64
Analyste	n/a
Objectif de prix	n/a
Dividendes	$0.87 (3.7%)
Date ex-dividende	22 mai 2026

À propos de FMS

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient'...

[En savoir plus]

Industrie Medical Care Facilities

Secteur Healthcare

Date d’introduction Sep 17, 1996

Employés 107,226

Bourse NYSE

Symbole boursier FMS

Site web https://www.freseniusmedicalcare.com

Profil complet de l’entreprise

Performance financière

En 2025, le chiffre d’affaires de Fresenius Medical Care s’élevait à 19.63B, soit une hausse de 1.51% par rapport aux 19.34B de l’année précédente. Le bénéfice s’élevait à 978.37M, soit une hausse de 81.88%.

États financiers

Surprise sur les résultats

Fresenius Medical Care a publié ses résultats trimestriels le Aug 3, 2026 :

Chiffre d’affaires de n/a est inférieur aux estimations de $0, avec -100.00% Baisse en glissement annuel.

EPS de 0.56 dépasse les estimations de 0.06, avec 21.74% croissance en glissement annuel.

Prochaine publication des résultats

Fresenius Medical Care AG devrait publier ses résultats le Nov 3, 2026, pendant les heures de marché.
Les analystes prévoient un chiffre d’affaires de ... Passer à l’offre supérieure

Actualités

1 semaine il y a · Motley Fool

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

U.S. referral execution gap offset by strong margin expansion and transformation savings.

1 semaine il y a · Zacks

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.

2 semaines il y a · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF

Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates the 5008X CAREsystem and ...

2 semaines il y a · Simply Wall St.

Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns

Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest the market may be pricing it on the ch...

2 semaines il y a · Simply Wall St.

Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?

Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer of the Care Delivery segment, res...

Page 1 de 2

Fresenius Medical Care AG (FMS)